Vivus (VVUS) Posts Q3 Loss of $0.30, Tops by 1c
More News related to VVUS
- Trading Review for Vivus Inc. Issued by Beacon Equity
- Vivus (VVUS) December volatility elevated at 102 into positive ED results
- VIVUS, Inc. (VVUS) Reports Positive Phase 3 Study of REVIVE
- VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile
- After-Hours Movers 11/17: LDK, VVUS Higher; ADSK, BWS, CNQR, TEN, EMS, DRYS Lower
Vivus, Inc. (NASDAQ: VVUS) reports Q3 loss of $0.30, 1 cents better than the analyst estimate of ($0.31). Revenue for the quarter was $4.40 million, which compares to the estimate of $5.31 million.
Related Categories
EarningsStocks Mentioned
+0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
